Proceedings: Penicillins: use of an animal model to predict bioavailability.
D000284:Administration, Oral; D000667:Ampicillin / Q000378:metabolism; D000818:Animals; D001702:Biopharmaceutics; D002214:Capsules; D004009:Dicloxacillin / Q000378:metabolism; D004285:Dogs; D004304:Dosage Forms; D006801:Humans; D007408:Intestinal Absorption; D010404:Penicillin V / Q000378:metabolism; D010406:Penicillins / Q000008:administration & dosage / Q000378:metabolism*; D013535:Suspensions; D013607:Tablets; D013997:Time Factors
D002214:Capsules; D004304:Dosage Forms; D010406:Penicillins; D013535:Suspensions; D013607:Tablets; D000667:Ampicillin; D004009:Dicloxacillin; D010404:Penicillin V